Author | Year | Study design | Country | Source of specimens | Gold standard | Type of LAMP | Bacterial species | TP | FP | FN | TN |
---|---|---|---|---|---|---|---|---|---|---|---|
Su | 2014 | Prospective | China | Clinical | Culture and latex agglutinationa | orfX-LAMP | MRSA | 557 | 0 | 9 | 101 |
Hanaki (a) | 2011 | Prospective | Japan | Clinical | PCR | LAMP | S. aureus | 195 | 0 | 0 | 10 |
Hanaki (b) | 2011 | Prospective | Japan | Clinical | PCR | LAMP | MRSA | 192 | 0 | 0 | 13 |
Metwally (a) | 2014 | Prospective | Egypt | Clinical | Standard proceduresb | LAMP | S. aureus | 36 | 0 | 0 | 24 |
Metwally (b) | 2014 | Prospective | Egypt | Clinical | Standard proceduresb | LAMP | MRSA | 19 | 0 | 0 | 41 |
Jiang (a) | 2020 | Prospective | China | Clinical | Culturec | m-LAMP-LFB | MRSA | 8 | 0 | 0 | 88 |
Jiang (b) | 2020 | Prospective | China | Clinical | Culturec | m-LAMP-LFB | S. aureus | 17 | 0 | 0 | 79 |
Kashani (a) | 2020 | Prospective | Iran | Clinical | Cultured | m-LAMP | S. aureus | 49 | 0 | 0 | 4 |
Kashani (b) | 2020 | Prospective | Iran | Clinical | MIC and disk diffusion | m-LAMP | MRSA | 37 | 4 | 0 | 12 |
Henares | 2017 | Prospective | Spain | Clinical | Cultured | eazyplex MRSA test system | S. aureus | 5 | 1 | 1 | 44 |
Rödel (a) | 2017 | Prospective | Germany | Clinical | Routine species identificationd | eazyplex® MRSA | S. aureus | 31 | 2 | 0 | 106 |
Rödel (b) | 2017 | Prospective | Germany | Clinical | Routine species identificationd | eazyplex® MRSA | MRSA | 6 | 0 | 0 | 25 |
Nawattanapaiboon (a)e | 2016 | Prospective | Thailand | Clinical | Culturef | LAMP-LFD | MRSA | 28 | 0 | 2 | 16 |
Nawattanapaiboon (b) | 2016 | Prospective | Thailand | Clinical | Culturef | LAMP-LFD | MRSA | 52 | 0 | 0 | 20 |
Lim | 2013 | Prospective | Malaysia | Clinical | PCR | Loopamp DNA amplification kit | S. aureus | 99 | 0 | 0 | 25 |
Leikeim (a) | 2019 | Retrospective | Germany | Clinical | Cultureg | eazyplex® MRSA and eazyplex® MRSA plus test strips | S. aureus | 230 | 5 | 1 | 561 |
Leikeim (b) | 2019 | Prospective | Germany | Clinical | Cultureg | eazyplex® MRSA and eazyplex® MRSAplus | MRSA | 32 | 2 | 0 | 763 |
Chen (a) | 2020 | Prospective | China | Clinical | Cultureh | m-LAMP-LFB | S. aureus | 28 | 0 | 0 | 35 |
Chen (b) | 2020 | Prospective | China | Clinical | Cultureh | m-LAMP-LFB | MRSA | 12 | 0 | 0 | 51 |